These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8129188

  • 1. Apolipoproteins C-II and C-III in peripheral arterial disease.
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Colletta A, Paradiso M, Cordova C.
    Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 3. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ, Bard JM, Fruchart JC, Ordovas JM, Wilson PF, Schaefer EJ.
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC, Alaupovic P, Cox DW, Little JA.
    Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
    [Abstract] [Full Text] [Related]

  • 5. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
    Briones ER, Mao SJ, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA.
    Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [Abstract] [Full Text] [Related]

  • 7. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE.
    Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665
    [Abstract] [Full Text] [Related]

  • 8. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
    Liu BW, Shao MZ, Yuan HJ, Wu ZF, Zhang ZH, Fu MD, Zhang RJ, Fan P.
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
    [Abstract] [Full Text] [Related]

  • 9. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E, Herbeth B, Paille F, Steinmetz J, Artur Y, Siest G.
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
    Ohta T, Matsuda I.
    Clin Chim Acta; 1985 Apr 15; 147(2):145-54. PubMed ID: 3921292
    [Abstract] [Full Text] [Related]

  • 11. Influence of apolipoproteins on the anatomical distribution of arterial disease.
    Wiseman SA, Powell JT, Barber N, Humphries SE, Greenhalgh RM.
    Atherosclerosis; 1991 Aug 15; 89(2-3):231-7. PubMed ID: 1686549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Serum lipids and apolipoproteins AI, B100, CI and CII in patients with apoplexy].
    Liu BW, Zhang ZH, Wu ZF, Fu MD, Zhang RJ, Fan P, Zhang P, Hu CH, Luo ZM, She LM.
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Mar 15; 20(1):9-12. PubMed ID: 2507441
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov 15; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 15. Alterations in levels of apolipoprotein C-III and C-II/C-III ratios in patients with liver disease.
    Koga S, Yamamoto K, Ibayashi H.
    Gastroenterol Jpn; 1984 Feb 15; 19(1):65-71. PubMed ID: 6724249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E, Rosseneu M, Bury J, Stul M, Lamberigts G, De Moor P.
    J Clin Endocrinol Metab; 1985 Nov 15; 61(5):882-9. PubMed ID: 3930554
    [Abstract] [Full Text] [Related]

  • 18. Apo B/Apo A-I ratio in central and peripheral arterial diseases.
    Lima LM, Carvalho Md, Sabino Ade P, Mota AP, Fernandes AP, Sousa MO.
    Arq Bras Endocrinol Metabol; 2007 Oct 15; 51(7):1160-5. PubMed ID: 18157393
    [Abstract] [Full Text] [Related]

  • 19. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR.
    Metabolism; 2005 Feb 15; 54(2):227-34. PubMed ID: 15690318
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.